PATENT CLAIM ANALYSIS

Application Number: 16087034
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-04
Patent Classification: ["424", "462000"]

Abstract:
The present invention relates to a pharmaceutical composition comprising an HDAC inhibitor, a pharmaceutically acceptable acid or salt thereof or a mixture of the acid and salt, provided both in a immediate release form and in an extended release form wherein 70-90 weight % of the HDAC inhibitor is provided in the immediate release form and the remainder of the HDAC inhibitor is provided in the extended release form. In further aspects the present invention relates to a kit comprising a number of doses of an HDAC inhibitor, a pharmaceutically acceptable acid or salt thereof or a mixture of the acid and salt thereof provided both in an immediate release form and in an extended release form. In still further aspects the present invention relates to an HDAC inhibitor, a pharmaceutically acceptable acid or salt thereof or a mixture of the acid and salt, provided in both an immediate release form and an extended release form, for use in a method of pretreating cancer, and a method of pretreating cancer using said HDAC inhibitor provided both in said immediate release form and said extended release form. Further aspects relate to combination treatment of cancer and to a dispenser for a blister pack.

Claim (Index 12):
A method of pretreating cancer comprising administrating an HDAC inhibitor, a pharmaceutically acceptable acid or a salt thereof or a mixture of the acid and the salt, wherein the HDAC inhibitor, the pharmaceutically acceptable acid or the salt thereof or the mixture of the acid and the salt is provided in both an immediate release form and in an extended release form, wherein 70-90 weight % of the HDAC inhibitor is provided in the immediate release form and the remainder of the HDAC inhibitor is provided in the extended release form,wherein the HDAC inhibitor is administered to a human suffering from cancer.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 97.0
- Lexical Diversity: 3.67241
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15074768', '14344314', '15386834', '14069233', '14845263']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6974226536618156
- 35 USC 102 Novelty (BERT): 0.528774064586251
- Combined Prediction Score: 0.6805577947542591
- Mean Citation Score: 257.38567600000005
- Max Citation Score: 353.88733
- Similarity Product: 270.0928165560055

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test